How protein interactions drive cellular death

July 14, 2017

Researchers at the Universities of Tübingen and Konstanz, the Ruhr-Universität Bochum, the Max Planck Institute of Intelligent Systems in Stuttgart, and the German Cancer Research Centers have worked together to gain new insights into a protein network which regulates the programmed break down of cells, also known as apoptosis. These Bcl-2 proteins are difficult to investigate as they exchange between the cell's watery cytoplasm and its oil-like membranes. There are only a few methods which can be used to analyze protein interactions in both environments. With a special type of spectroscopic analysis the team decoded the complex interplay of three components in the network. Their findings are published in the latest Nature Communications.

Cell suicide squad

"Our good health depends on the strict regulation of cell division and cell death," says Dr. Stephanie Bleicken, who has recently moved from the University of Tübingen to Bochum's "Resolv" excellence cluster and the research group for electron paramagnetic resonance spectroscopy. When these mechanisms fail, cancer and neurodegenerative disorders can result. "Apoptosis - a kind of suicide plan for cells - is an important safety mechanism for the body to get rid of damaged, aged, or unneeded cells," Bleicken says.

The Bcl-2 protein family determines when apoptosis begins. Some members of the family set off processes in the cell which lead to cellular death, for example by opening pores in the membrane of the mitochondria - the cell's power plants. These pores release substances which set off apoptosis as an unstoppable process. Other members of the Bcl-2 family prevent the pores opening - thereby preventing the cellular death process. So interaction between Bcl-2 proteins is key to understanding apoptosis.

A playground for proteins

In a new study the researchers shed light on the coordination of the Bcl-2 network, using fluorescence correlation spectroscopy. In their simplified laboratory model they produced three of the protein network's main components and investigated them in an environment modeling roughly on that of the cell.

Living cells are made up of thousands of different molecules which carry out countless interactions and can set off uncounted reactions," says University of Tübingen's Professor Ana García-Sáez. "In order to understand individual components in this complex network, it helps to observe them initially in a highly simplified environment, to which you can keep adding new components." The researchers analyzed the proteins in environments which simulated the cytoplasm or the mitochondrial membrane.

Different interactions in the membrane and cytoplasm

The proteins' interactions were heavily dependent on their environment. Different interactions were possible in the membranes compared to the cytoplasm. "That was an important finding because the interactions in the membrane are essential in deciding whether apoptosis begins," García-Sáez says. "But this environment is technically much more difficult to investigate than the cytoplasm."

Because the researchers could compare proteins in both environments, they were able to reconcile and incorporate earlier findings which had appeared to yield contradictory results. "The Bcl-2 proteins regulate apoptosis, which in turn is closely linked with diseases such as cancer. Better understanding of the functions of these proteins is critical to achieve a good starting-point for the development of new medications," the researchers say.

Ruhr-University Bochum

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to